ResearcherUniversity of GenevaActive in the last 2 years
Mikaël J. Pittet
Matched on ORCID iD 0000-0002-2060-4691; OpenAlex author ID A5005627779; NIH RePORTER profile ID 8092146. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 14
2021: 1 grant · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 3
- Driving tumor-associated macrophages to a CXCL9Hi/SPP1Low phenotype eliminates pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2026.102938↗
- IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against pancreatic cancer in mice with obesity. Co-author DOI 10.1136/jitc-2024-011404↗
- Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic… Co-author DOI 10.1158/1078-0432.ccr-22-1630↗
Grants 1
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rakesh K. Jain · 2 shared papers, 1 shared grant, 2021–2025 · strength 0.83
- Grant Reprogramming PDAC tumor microenvironment to improve immunotherapy U01CA224348↗
- Paper IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against… DOI 10.1136/jitc-2024-011404↗
- Paper Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Can… DOI 10.1158/1078-0432.ccr-22-1630↗
- Yves Boucher · 1 shared paper, 1 shared grant, 2021–2023 · strength 0.59
- Dai Fukumura · 2 shared papers, 2023–2025 · strength 0.38
- Paper IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against… DOI 10.1136/jitc-2024-011404↗
- Paper Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Can… DOI 10.1158/1078-0432.ccr-22-1630↗
- Nilesh P. Talele · 2 shared papers, 2023–2025 · strength 0.38
- Paper IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against… DOI 10.1136/jitc-2024-011404↗
- Paper Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Can… DOI 10.1158/1078-0432.ccr-22-1630↗
- Dan Gabriel Duda · 2 shared papers, 2023–2025 · strength 0.38
- Paper IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against… DOI 10.1136/jitc-2024-011404↗
- Paper Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Can… DOI 10.1158/1078-0432.ccr-22-1630↗
- Yen T.M. Nguyen · 1 shared paper, 2026 · strength 0.24
- Federico De Stefano · 1 shared paper, 2026 · strength 0.24
- Ralph Weissleder · 1 shared paper, 2026 · strength 0.24
- Andrew Scott Liss · 1 shared paper, 2026 · strength 0.24
- Theodore Sunki Hong · 1 shared paper, 2023 · strength 0.14
- Carlos F. Fernandez-del Castillo · 1 shared paper, 2023 · strength 0.14
- Mari A. Mino-Kenudson · 1 shared paper, 2023 · strength 0.14
- David P. Ryan · 1 shared paper, 2023 · strength 0.14
- Jennifer Yon-Li Wo · 1 shared paper, 2023 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.